We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Valsartan Recalled In United States Due To Carcinogenic Ingredient

(July 17, 2018, 2:04 PM EDT) -- SILVER SPRING, Md. — Three generic drug manufacturers have voluntarily recalled the high blood pressure and heart failure drug valsartan after discovering that they contain a N-nitrosodimethylamine (NDMA), which is classified...
To view the full article, register now.